Jump to content

Recommended Posts

Posted

Saw this advertisement. A little checking into the subject brought this to light -

Issue

1. Two complainants challenged whether the efficacy claims for the product were misleading and could be substantiated.

2. The ASA challenged whether the claims that the product could treat arthritis discouraged essential treatment for a condition for which medical supervision should be sought.

Response

Finitro said they were unable to substantiate the claims because they were based on their own research which was confidential and could not be published.

https://www.asa.org.uk/rulings/finitro-a12-183032.html

 

Seems that some prior due diligence on this subject would have discouraged this ad appearing in the first place.

 

Be Aware. Beware.

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...